Information for "The chlorinlipid nanovesicle nucleus medication for increased beneficial outcomes of lung cancer simply by internal radiotherapy together with the Cerenkov radiationinduced photodynamic treatments"
From EECH Central
Basic information
Display title | The chlorinlipid nanovesicle nucleus medication for increased beneficial outcomes of lung cancer simply by internal radiotherapy together with the Cerenkov radiationinduced photodynamic treatments |
Default sort key | The chlorinlipid nanovesicle nucleus medication for increased beneficial outcomes of lung cancer simply by internal radiotherapy together with the Cerenkov radiationinduced photodynamic treatments |
Page length (in bytes) | 3,535 |
Page ID | 1439341 |
Page content language | English (en) |
Page content model | wikitext |
Indexing by robots | Allowed |
Number of redirects to this page | 0 |
Page protection
Edit | Allow all users (infinite) |
Move | Allow all users (infinite) |
Edit history
Page creator | Brastory3 (Talk | contribs) |
Date of page creation | 04:04, 5 May 2024 |
Latest editor | Brastory3 (Talk | contribs) |
Date of latest edit | 04:04, 5 May 2024 |
Total number of edits | 1 |
Total number of distinct authors | 1 |
Recent number of edits (within past 90 days) | 1 |
Recent number of distinct authors | 1 |